Catalytic domain comparisons of human fibroblast-type collagenase, stromelysin-1, and matrilysin

被引:11
|
作者
Windsor, LJ
Steele, DL
LeBlanc, SB
Taylor, KB
机构
[1] UNIV ALABAMA,DEPT MICROBIOL,BIRMINGHAM,AL 35294
[2] UNIV ALABAMA,DEPT BIOCHEM & MOL GENET,BIRMINGHAM,AL 35294
来源
关键词
matrix metalloproteinase; collagenase; matrilysin; stromelysin;
D O I
10.1016/S0304-4165(96)00102-X
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The propeptide plus the catalytic domain of human fibroblast-type collagenase, stromelysin-1, and matrilysin were expressed in Escherichia coli to directly compare the properties of all three catalytic domains utilizing the same assays. Truncated fibroblast-type collagenase (mini-CL), truncated stromelysin-l (mini-SL-1), and matrilysin, like their native counterparts, could be activated by organomercurials, trypsin, or SDS. The mini-CL and mini-SL-l displayed catalytic properties similar to their native counterparts, except that the mini-CL could not cleave native type I collagen. The k(cat)/K-m for matrilysin (355 mu M(-1) h(-1)) on the synthetic Mca-peptide was much higher than that for mini-CL (69 mu M(-1) h(-1)) or mini-SL-1 (23.6 mu M(-1) h(-1)). Mini-SL-1 and matrilysin, but not mini-CL, were capable of superactivating collagenase thus increasing the rate of collagen cleavage. Mini-CL and mini-SL-1, but not matrilysin, were able to form SDS-stable complexes with TEMP-1 when co-incubated with an organomercurial and TIMP-1. The second-order rate constant (k(on)) for TEMP-1 inhibition of mini-CL and mini-SL-1 were similar, 0.635 . 10(5) M(-1) s(-1) and 1.52 . 10(5) M(-1) s(-1), respectively. The k(on) for TIMP-1 inhibition of matrilysin was lower (0.130 . 10(5) M(-1) s(-1)) supporting the observation that no SDS stable complexes were detected. This study demonstrates that these catalytic domains are distinct and play a major role in the specificity of these enzymes in regard to rate of catalysis, TIMP-1 binding, and superactivation of collagenase.
引用
收藏
页码:261 / 272
页数:12
相关论文
共 50 条
  • [41] Expression of urokinase plasminogen activator mRNA preceeds interstitial collagenase and stromelysin-1 in lesions of dermatitis herpetiformis
    Airola, K
    Reunala, T
    Salo, S
    SaarialhoKere, U
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1996, 106 (04) : 360 - 360
  • [42] Differential regulation of stromelysin-1 (matrix metalloproteinase-3) and matrilysin (matrix metalloproteinase-7) in baboon endometrium
    Cox, KE
    Sharpe-Timms, KL
    Kamiya, N
    Saraf, M
    Donnelly, KM
    Fazleabas, AT
    JOURNAL OF THE SOCIETY FOR GYNECOLOGIC INVESTIGATION, 2000, 7 (04) : 242 - 248
  • [43] Differential Regulation of Stromelysin-1 (Matrix Metalloproteinase-3) and Matrilysin (Matrix Metalloproteinase-7) in Baboon Endometrium
    K. E. Cox
    Kathy L. Sharpe-Timms
    N. Kamiya
    M. Saraf
    K. M. Donnelly
    A. T. Fazleabas
    The Journal of the Society for Gynecologic Investigation: JSGI, 2000, 7 (4): : 242 - 248
  • [44] The cleavage of pro-urokinase type plasminogen activator by stromelysin-1
    Orgel, D
    Schroder, W
    Hecker-Kia, A
    Weithmann, KU
    Kolkenbrock, H
    Ulbrich, N
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 1998, 36 (09) : 697 - 702
  • [45] SYNTHESIS AND EXPRESSION OF THE FIBROBLAST-TYPE FIBRONECTIN RECEPTOR IN HUMAN-MONOCYTES
    BROWN, DL
    PHILLIPS, DR
    CHARO, IF
    ARTERIOSCLEROSIS, 1988, 8 (05): : A670 - A670
  • [46] Influence of heparin(s) on the interleukin-1-β-induced expression of collagenase, stromelysin-1, and tissue inhibitor of metalloproteinase-1 in human gingival fibroblasts
    Gogly, B
    Hornebeck, W
    Groult, N
    Godeau, G
    Pellat, B
    BIOCHEMICAL PHARMACOLOGY, 1998, 56 (11) : 1447 - 1454
  • [47] Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1
    Franz-Xaver Gomis-R¨th
    Klaus Maskos
    Michael Betz
    Andreas Bergner
    Robert Huber
    Ko Suzuki
    Naoki Yoshida
    Hideaki Nagase
    Keith Brew
    Gleb P. Bourenkov
    Hans Bartunik
    Wolfram Bode
    Nature, 1997, 389 : 77 - 81
  • [48] Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1
    GomisRuth, FX
    Maskos, K
    Betz, M
    Bergner, A
    Huber, R
    Suzuki, K
    Yoshida, N
    Nagase, H
    Brew, K
    Bourenkov, GP
    Bartunik, H
    Bode, W
    NATURE, 1997, 389 (6646) : 77 - 81
  • [49] Expression of urokinase-type plasminogen activator, stromelysin 1, stromelysin 3, and matrilysin genes in lung carcinomas
    Bolon, I
    Devouassoux, M
    Robert, C
    Moro, D
    Brambilla, C
    Brambilla, E
    AMERICAN JOURNAL OF PATHOLOGY, 1997, 150 (05): : 1619 - 1629
  • [50] IN-VITRO REGULATION OF STROMELYSIN-1 IN HUMAN ENDOMETRIAL STROMAL CELLS
    SCHATZ, F
    PAPP, C
    TOTHPAL, E
    AIGNER, S
    HAUSKNECHT, V
    KRIKUN, G
    GORDON, RE
    BERKOWITZ, R
    LOCKWOOD, CJ
    INHIBITION OF MATRIX METALLOPROTEINASES: THERAPEUTIC POTENTIAL, 1994, 732 : 479 - 481